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EXPRESSION OF a4J31 INTEGRIN ON TISSUE EOSINOPHILS IN THE
AUGUST RAT
John C. Phipps, M.S.
Western Michigan University, 1996
The integrin a4J31 is expressed on a wide variety of peripheral leukocytes, and
functions in recruitment of these cells to sites of inflammaiton. We infected august
(AUG) rats with the helminth parasite Nippostrongylus brasiliensis and later used
leukocytes from the peritoneum of the sensitized animals and antibodies against a4J31
integrin to localize that adhesion molecule on the cell surfaces after antigen challenge.
We found that after antigen challenge, eosinophils, monocytes, and small lymphocytes,
but not mast cells, expressed a4J31 integrin if the animals had been previously infected,
but cells from uninfected animals did not show expression of this molecule. Our study
describes a novel protocol for immunohistochemical analysis of rat eosinophils.
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INTRODUCTION

Adhesion Molecules
Background
In 1889, Julius Cohnheim reported an important obseivation whose details are
only now becoming understood in a meaningful way. He noted that in sites of allergic
inflammation, white corpuscles separated themselves from red corpuscles, and
attached themselves to the postcapillary venules, in a process we now refer to as
margination. He further suggested that the method of attachment was some type of
"molecular glue".
In recent decades this molecular glue has been studied and grouped into
several families of "adhesion molecules", including: selectins, immunoglobulin-like
molecules and integrins. Adhesion molecules are generally proteins or glycoproteins
expressed on the surface of a wide variety of cells including migratory cells of the
immune system as well as endothelial cells (EC).

Interactions between adhesion

molecules and their ligands, which are frequently other adhesion molecules or
extracellular matrix molecules, allows the selective recruitment of cells from the
vasculature to the site of allergic reaction, infection, or other inflammatory state.
Adhesion molecules also regulate trafficking of immune effector cells to various sites
in the body, such as lymphoid tissue. This adhesion is crucial to immune system
function as well as non-inflammatory systems, such as development and differentiation
of tissues.

1
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g& 1 a Multifunctional Integrin
One large family of cell adhesion molecules, widespread in the body, is the
integrins. Integrins are heterodimeric proteins (Figure 1), composed of varying a and
f3 subunits in a noncovalent association (reviewed in Hynes, 1992).

1bis

organizational scheme has led to the now-preferred system of nomenclature in which
integrins are named according to their a and f3 subunits. Thus VLA-4 is now referred
to as a4f31. The older designation Very Late Activation Antigen (VLA) was based on
experiments (Hemler, 1990) in which the expression of both VLA-1 and VLA-2 was
dramatically increased on cultured lymp hocytes after 4 weeks. Current knowledge
indicates, however, that most cells in the body express at least some integrins
constitutively, and thus the VLA designation is gradually falling into disuse.
The f3 subunits, which vary in size from about 90kD to l l 0kD, will generally
associate with more than one a subunit, leading to subfamilies of integrins grouped
according to the f3 subunit. For instance, all the integrins which had been termed
"VLA" antigens are from the f31 subfamily, while the f3 2 subfamily contains the species
Leukocyte Function-associated Antigen (LFA)-1 and Mac-1 (C3bi receptor). The f32
subfamily are the only integrins still referred to commonly by their CD numbers:
CD l lx/CD18. The three major f3 subunits in humans: f31, f32 and f33, have been
completely sequenced (reviewed in Hemler, 1990) and show 44-47% homology. In
particular, four repeating regions rich in cysteine are highly conserved in the C
terminal half of the molecule. These repeats appear to lie in the extracellular region
(see Figure 1).
The a subunits are somewhat larger at 120-180kD (Hynes, 1992) and
generally contain binding sties for divalent cations, which have been shown to be
necessary for the :function of some integrins (Gailit & Rouslahti, 1988). The various a
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Generalized Structure oflntegrin Heterodimer. (Adapted from Hynes,
1992, Hemler, 1990; Mufi.oz, Senador, Sanchez-Madrid and Teixid6 1996.)

subunits are slightly less similar to each other than the

p

subunits, at 20-30%

homology. The association region for the two molecules is unknown, although studies
of altered subunits without transmembrane domains did appear to form normal
heterodimers (Bodary, Lipari, Muir, Napier, Pitti & McLean, 1991). Most a subunits
appear to selectively associate with only one P chain, however there are notable
exceptions. One of the most interesting is the heterodimer a4 p 7, which some studies

have found to bind to the same ligand binding sites as a4 p 1 (Ruegg, Postigo, Sikorski,
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Butcher, Pytela & Erle, 1992). In another study (Chan, Elices, Mmphy & Helmer,
1992), the affinity of the rarely-found a4 (3 7 for the ligands of a4 (3 1 , was found to be
considerably lower, and dependent on some form of activation. 1bis suggests the
possibility that a4 (3 1/ligand specificity may be largely determined by the a subunit.
Supporting that notion is the work of Mu.iioz, Serradoi:, Sanchez-Madrid and Teixido
(1996), in which changes in the amino acid residues Arg89-Asp90 in the a4 subunit
reduced both aggregation of transfected K562 cells and their adhesion to fibronectin,
while substitutions at the nearby Gln101, Pro 102 and Ile108 had little or no effect.
Notably, adhesion to VCAM-1 was not affected by these mutations.
The a4 (3 1 integrin is expressed on many leukocyte types including: eosinophils,
peripheral blood lymp hocytes, monocytes, B and T cell lines and NK cells, among
others.

Significantly, it is absent on neutrophils (Pigott, Power, 1993; Wardlaw,

Symon & Walsh, 1994).

Because a4 (3 1 is expressed by eosinophils but not

neutrophils, it appears to function as a system for preferentially recruiting eosinophils
into tissues.
As stated previously a4 (3 1 is multifunctional in that it facilitates both adhesion
to extracellular matlix (ECM) and cell-cell adhesion via different ligands. Intercellular
binding is accomplished through the ligand Vascular Cell Adhesion Molecule-1
(VCAM-1) which is expressed on vascular endothelial cells (EC). In human in vitro
cell systems, eosinophils have been shown to adhere to cultured endothelial cells via
the a4 (3 1NCAM- l binding system (Dobrina, Menegazzi, Carlos, Nardon, Cramer,
Zacchi, Harlan & Patriarca, 1991, and Weller, Rand, Goelz, Chi-Rosso & Lobb,
1991). Both studies found that binding was abrogated in the presence of either anti
VLA-4 or anti-ICAM-1 monoclonal antibodies (mAb), but not in the presence of
unrelated control antibodies. In vivo video microscopy studies in rabbit have shown
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that a4 p 1 contributes to eosinophil rolling in venules (Sriramarao, von Andrian,
Butcher, Bourdon & Broide, 1994). Once again, mAbs against a4 p 1 inhibited the
phenomenon, while control (anti-CD18) mAbs had no effect.

Finally, TA-2, a

monoclonal antibody against a4 p 1 , was found to inhibit the in vivo migration of small
lymphocytes to inflamed or cytokine-treated skin in a rat model (Issekutz, 1991).
Fibronectin, a glycoprotein which is a major component of ECM, is the other
ligand of a4f3 1 . While VCAM-1 has a greater affinity for a4 p 1 than does fibronectin
(Chan & Aruffo, 1993), it has been shown that the integrin/fibronectin interaction has
profound physiological effects on eosinophils (Anwar, Moqbel, Walsh, Kay &
Wardlaw, 1993; Anwar, Walsh, Cromwell, Kay & Wardlaw, 1994).

The classic

binding portion of fibronectin is the peptide sequence arginine-glycine-aspartic acid
(RGD) which is present in several ECM proteins including fibronectin and vitronectin
(Hynes, 1992; Anwar, Walsh, Cromwell, Kay & Wardlaw, 1994). VLA-5(a5 p 1 ),
which is a familiar fibronectin binding integ1in, binds to the RGD sequence, as does a
rlbf33, and all of the

ayp (Hynes, 1992).

However, the a4f31 integrin appears to bind

to fibronectin at a unique region which contains several distinct binding sites including:
an incompletely characterized portion of the heparin II domain, and two sites in the
lllCS region which have been designated CS-1 and CS-2 (Hemler, 1990).

The

multiplicity of binding sites for the a4 p 1 /fibronectin associations suggests that this is
an important interaction for the cell.
Can a4l21 /Ligand Binding Initiate Intracellular Signal Transduction?
It may be too simplistic to suppose that adhesion molecules act simply as a
molecular glue, holding cells to each other or to ECM. On a strictly molecular basis,
several obseivations suggest integrins may have functional roles in addition to their
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extracellular binding capability. As mentioned earlier, there is approximately 20-30
percent homology between the different classes of a subunits within a species
(reviewed in Hemler, 1990).

When only the cytoplasmic domains are examined,

however, there is very little homology. Yet the cytoplasmic domain of a given a
subunit is highly conserved between species. For example, the cytoplasmic domain of
human a 3 shares 31 of 36 amino acids with its chicken counterpart (Hemler, 1990).
Taken together, these observations suggest that integrins may each have specific
functionalities within the cytoplasm, which are highly conserved between species.
These functionalities may include carrying a signal to a second messenger inside the
cell, or alternately it could indicate that integrins simply bind to different components
of the cytoskeleton.
In a definitive study using human eosinophils, a4P1/fibronectin binding was
shown to enhance the cells' survival in vitro (Anwar, Moqbel, Walsh, Kay & Wardlaw,
1993).

This experiment examined the survival rate of eosinophils cultured in the

fibronectin-coated, bovine serum albumin-coated and uncoated wells over several days
and found that virtually all the eosinophils cultured without fibronectin had died after
96 hours, while 60% of the eosinophils in the fibronectin-coated wells were alive as
measured by trypan blue exclusion. Antibodies against fibronectin and a4 p 1 integrin
inhibited this survival.

When the medium was analyzed, it was found to contain

granulocyte/macrophage colony-stimulating factor (GM-CSF), and interleukin-3 (IL3) in those wells which had contained fibronectin, but not in the other wells.
Additionally, in situ hybtidization examination of the eosinophils from the fibronectin
coated wells showed mRNA for GM-CSF.

These results indicate that a4 p 1

/fibronectin binding can initiate signal transduction, producing physiological responses
by the cell. In another study, binding to fibronectin caused cultured eosinophils to
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increase their production of leukotriene C4 (LTC4) over cells which were cultured
without fibronectin (Anwar, Walsh, Cromwell, Kay & Wardlaw, 1994). Finally, in the
work of Kassner, Alon, Springer and Hemler (1995), chimeric forms of a4f31, deficient
in the cytoplasmic domain of the a4 subunit were shown to alter some aspects of cell
movement such as spreading.
An additional level of complexity is added by the post-expression regulation of
integrin binding affinity. Although this process has been more fully characterized in
other integrins such as a11bp3, studies exist which have described a similar regulation
of a4p 1 . In one recent study using human peripheral blood eosinophils, (Kuijpers,
Mul, Blom, Kovach, Gaeta, Tollefson, Elices & Harlan, 1993), an "activating" anti p 1
mAb (8A2) is described which increased the level of eosinophil binding to :fibronectin
coated filters. This binding was blocked by the addition of the CS-1 fragment of
fibronectin, indicating that the binding was mediated by a4f3 1 and not a3f3 1 , or a5Pi,
both of which bind to the RGD sequence.

What makes this study particularly

interesting, is that while a4 p 1 integrin was locked in the higher-affinity binding state by
the 8A2, the eosinophils were completely blocked from migrating through the
fibronectin-coated filter. In contrast, eosinophils which had not been exposed to 8A2
were able to migrate through the filters coated with fibronectin. One could speculate
then, that a4f31/ECM interactions in vivo may depend on a modulation of the integrin
between high and low affinity states. Reasoning further, if the integrin could not be
controlled in this way, the cell might be locked in one position, and thus would not be
able to "crawl" through tissues to sites of inflammation. Other recently published data
(Yednock, Cannon, Vandevert, Goldmach, Shaw, Ellis, Liaw, Fritz & Tanner, 1995)
indicate the possibility that changes in a4 p 1 conformation may be induced by the
ligands themselves. Using leukocytic cell lines, these researchers describe an anti-a4 p
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1 mAb which only recognizes its epitope when the integrin is in the high-affinity state.
The study found that nanomolar concentrations of VCAM-1 or micromolar
concentrations of the a4� 1 binding portion of fibronectin could induce the mAb to
bind, indicating a conformational change to the higher affinity state. Of course, much
remains to be learned about the intriguing field of integrin regulation.
Eosinophils and the August Rat
The Eosinophil
Eosinophils are bone-marrow-derived granular leukocytes, which have been
shown to be major participants in allergic inflammation, asthma, and host defenses in
parasitism (reviewed in Smith & Cook, Ed., 1993).

Generally, eosinophils are

distinguished from other leukocytes on the basis of their morphology and characteristic
staining properties. In particular, a subset of the cytoplasmic granules referred to as
the secondary or specific granules, has a high affinity for acid stains. Rat eosinophils
are particularly easy to identify on the basis of their unique, donut-shaped nucleus
(Figure s. 7,9).
It is well established that eosinophils will respond to several chemotactic
factors including platelet activating factor (PAF), C5a and others (reviewed in
Giembycz & Barnes, 1993), and that upon stimulation with the appropriate factors,
they can migrate across vascular endothelium as well as epithelium (Resnick, Colgan,
Parkos, Delp-Archer, McGuirk, Weller & Madara, 1995). As discussed earlier, this
movement is referred to as trafficking when it involves the normal migration of
immune cells into and out of lymphoid tissues, or recruitment in the case of response
to an inflammatory stimulus, and is common among many types of immune cells.
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Much of the eosinophil research in recent decades has revolved around their
participation in asthma. Although this is plainly a pathological condition and therefore
likely distinct from eosinophils' protective role in immunity, much knowledge has been
gained which can illuminate the functions of the eosinophil as a member of the healthy
immune system. Eosinophils have been associated with the late phase of asthmatic
response, and have been found to migrate in predictable patterns in asthma models.
Furthermore, studies using blocking antibodies to various adhesion molecules have
been shown to change that migration pattern, illustrating that linkage between
adhesion molecule expression and cell migration in asthma.

In one particularly

interesting study using sheep as the animal mode� mAbs against a4 were given before
ascaris antigen challenge in the airways (Abraham, Sielscak, Ahmed, Cortes, Lauredo,
Kim, Pepinsky, Benjamin, Leone, Lobb & Weller, 1994), and were found to decrease
late-phase airway hyp erresponsiveness by 75%.

Upon histological examination,

however, it was found that eosinophil numbers in the mAb-treated animals were not
significantly different than in the control group. Moving to an in vitro test system,
these same researchers found that their mAb was able to inhibit PAF-stimulated
eosinophil peroxidase release, leading them to conclude that the mAb they had been
using elicited its effects by altering eosinophil function rather than recruitment.
This points out the complex layers of function in immune response, and a
distinction between recruitment of an eosinophil, and activation of that same cell. It
has been shown in the literature that eosinophils are multifunctional; or stated in other
words, that depending on the signals it receives from its environment, an eosinophil
can exhibit varying responses. This is a movement away from the more classic view of
eosinophils as cells which exist solely to release granule contents when functionally
"activated".
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One traditional parameter for describing an eosinophil's functional state is its
density.

Many researchers purify eosinophils from blood by means of a density

gradient using metrizamide, Percoll or other compounds, utilizing the fact that, in
healthy individuals, eosinophils generally have the greatest buoyant density of all
leukocytes found in the peripheral blood (Owen, 1993). Additionally, eosinophils
from the blood of individuals who had experienced helminth infection were found to
be less dense than those of individuals who had not (De Simone, Donelli, Meli, Rosati
& Sorice, 1982), thus linking density profile with functional state.

The different

morphological status of the two groups has also been associated with the location of
the eosinophils; summioe up this physical heterogeneity in his 1993 review, Owen
noted "normodense eosinophils become hyp odense in the peripheral circulation and
migrate preferentially to the tissue microenvironment, . . . hyp odense eosinophils are
the phenotyp e which resides in the tissue microenvironment" (page 61).
It has been observed that outside the body, normodense eosinophils do not
remain viable for long periods of time, however their survival can be significantly
prolonged by co-culture with fibroblasts, or by addition of cytokines such as GM-CSF,
IL-3 or IL-5 (Owen, 1993).

This increased survival is accompanied by a

transformation from the normodense to the hyp odense morphology. These hyp odense
eosinophils share many of the alterations in functional capability displayed by the
hyp odense eosinophils from patients with eosinophilia (see Owen 1993).
All of this information leads to the conclusion that eosinophils are differentially
stimulated in vivo for certain physical and chemical functions, such as increased
helminth killing capability or prolonged survival (Owen, Rothenberg, Silberstein,
Gasson, Stevens, Austin & Soberman, 1987), and that without a precise sequence of
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stimulatory events, the cells will not display those functions. Thus specific functional
stimulation can only be approximated in vitro if the appropriate stimuli are known.
The August Rat as a Model of Eosinophilia
The August (AUG) rat is unusual among animal models in that it has high
numbers of eosinophils in the peritoneal cavity, independently of external stimulus
(Mackenzie, Jungery, Taylor & Ogilvie, 1981).

The only other rat in which this

phenotypic trait has been described is the Am-1(2)/Tor rat (Pimenta & De Sousa,
1982). In the AUG rat, these cells are part of a mixed-cell population containing
eosinophils, mast cells, mononuclear phagocytes and small lymp hocytes. In an adult
male AUG rat this population numbers on the order of 3x107 cells per animal
Notably, no neutrophils are detectable in the peritoneal lavage of the AUG rat.
Because these cells are easily removed with a simple peritoneal lavage using a buffered
isotonic medium, eosinophils may be isolated without immunological stimulation or
elaborate isolation procedures. Most eosinophil studies procure cells by an inhaled
antigen challenge followed by a pulmonary lavage, or by collecting large quantities of
blood and removing the eosinophils with negative immunological selection or an
automated cell sorter. Both of these methodologies involve significant insult to the
cells, and are further removed from the natural in vivo condition. Our study used the
mixed population as it was found in the anima� without segregating the eosinophils.
Nippostrongylus brasiliensis Infection in the Rat
Since the earliest days of eosinophil research in the late 19th century, scientists
have been studying the relation of these cells to helminth parasite infections (reviewed
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in Spry, 1988). This research has continued up to the present, and has been a major
contributor to our understanding of eosinophil biology, not only as it relates to
parasitism, but also in terms of the fundamental mechanisms of eosinophil structure
and function. Helminth infection has been associated with a localized eosinophilia at
the site of the parasite in a wide variety of models (reviewed in Butterworth & Thome,
1993), often preceded by a peripheral blood eosinophilia. The eosinophilia has been
found to be concurrent with elevated serum levels of immunoglobulin (Ig)E, which
may be relevant to the localized eosinophilia (Butterworth & Thome, 1993).

Nippostrongylus brasiliensis (Nb) is an rodent enteric parasite whose definitive
host is the rat. Infective larvae (�) enter the animal through the skin, burrowing
through tissue until encountering a blood vessel.

Entering the vasculature, they

migrate to the lungs, where they cross the pulmonary epithelium and molt.

The

resulting L4 enter the digestive system via the esophagus, and eventually arrive in the
small intestine. By 3-16 days after the initial infection, the worms molt again, thus
enter the adult stage (L5), during which they mate and lay eggs. The eggs are passea
out of the animal in the feces starting around day 8-9 post-infection (Eversole, 1996).
As in other animal models, a localized eosinophilia has been reported at the site
of migrating Nb larvae in rats (Mackenzie & Spry, 1983). Nb infection has also been
associated with eosinophilia in the blood as well as in other tissues, and in the AUG rat
this tissue eosinophilia has recently been described (Eversole, 1996).

Eosinophil

numbers in the peritoneal cavity were shown to increase rapidly from 11-20 days after
a primary infection with Nb.
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Purpose of lbis Experiment
Operating under the hyp othesis that sensitized eosinophils from Nb-infected
animals may be differentially stimulated to produce a4 13 1 integrin, we attempted to
localize this molecule on the eosinophils after an in vitro treatment with antigen from
Nb.

To do this, we challenged cells from rats which had been infected with Nb and
a control group which had not, with Nb antigen. After treatments, the cells were
examined using fluorescent immunohistochemical methods. We selected a time point
for cell collection based on the period in which eosinophils were rapidly entering the
peritoneum, reasoning that a4 13 1 might be expressed at that time.

ASSAY DEVELOPMENT
Difficulties in Immunolabeling Rat Eosinophils
Although obtaining healthy, resting-state eosinophils is facilitated by the
existence of the AUG rat, there are inherent difficulties in using the standard
conjugated antibody markers with eosinophils in general.

First, the highly basic

granules of the eosinophils bind fluorescein molecules, resulting in unacceptable
background levels (eosin, for which eosinophils are named, is in fact a brominated
fluorescein derivative developed by the dye industry. See Figure 2).
Br

Second,

Br

0-<o

Eosin

Fluorescein
Figure 2.

Molecular Structures ofFluorescein and Eosin.

eosinophils autofluoresce under UV-excitation, obscuring less intense stains such as
rhodamine, rendering these stains unsatisfactory as well.

Third, peroxidase-linked

assays are unsuitable because of the well-known endogenous peroxidase activity of the
eosinophil (Spry, 1988).

Fourth, rat eosinophils possess endogenous alkaline

phosphatase activity, making that enzyme-linked marker system unsuitable for use in
14
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this model.

Finally, some unknown factor associated with the cells in this cell

population interfered with color development in systems using glucose oxidase,
although the nature of this interference remains undetermined.
We have overcome the difficulties associated with the fluorescein label,
however, by treating the cells with a compound described in the 1940's (Lendrum,
1944). Lendrum's chromotrope appears to bind to the specific granule contents more
effectively than does the fluorescein, essentially blocking that interaction.

1bis

compound has the added benefit of rendering the eosinophils easily visible without use
of any other staining agents.
Reagents
Except where noted, reagents were the same as those listed in Materials and

Methods. The glucose oxidase-linked assay was carried out using the ABC-GO kit
(Vector Laboratories, Burlingame, CA). The alkaline phosphatase-linked assay was
also performed with a Vector Laboratories kit, ABC-AP, and the levamisole solution
was also from Vector Laboratories. At various times, phosphate buffered saline (PBS)
with tween-20, PBS without tween-20, and reverse osmosis (RO) purified water were
assessed as washing agents. Fixation was done at various temperatures with methanol,
acetone, 10% neutral buffered formalin and air drying, in order to determine the most
effective fixation method for this assay.
Preliminary Research
Our first attempts at labeling these cells focused on systems using fluorescein
conjugated secondary mAb's. High background obscured any labeling that may have
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existed on the slides, and occurred even on the slides which had not been treated with
the primary antibody; the so-called negative control slides.

This suggested that

fluorescein would not be useful as the secondary marker in this cell population. To
confirm non-specific staining of rat eosinophils with fluorescein-containing reagents,
we ran a demonstration slide of non-stimulated AUG rat peritoneal leukocytes
(obtained and prepared as described in Materials and Methods). with one hour
gelatin blocking (to block nonspecific protein-protein interactions), followed by a wash
and fluorescein-conjugated anti mouse-lgG (the same secondary antisera described in
Materials and Methods). The results are visible in Figure 3. Since the antibody is
not significantly cross-reactive with any known epitopes in this cell preparation, the
staining that is visible in the micrograph is assumed to be the non-specific interaction
of the fluorescein with some intracellular component, possibly granular.
The autofluorescence which makes low-level stains such as rhodamine
problematic is visible in a preparation called a "sham", in which cells are treated with
no additional reagents after :fixation and a preliminary wash, showing only their own
inherent color properties under UV-excitation. An example of a sham prepared with
AUG rat peritoneal leukocytes is shown in Figure 4.
We decided against attempting to adapt a peroxidase-based assay system,
because of previous difficulties associated with quenching the endogenous enzyme
activity in eosinophils, particularly those from the AUG rat (Mackenzie, unpublished
observations).
Next, we explored the possibility of using a commercially available alkaline
phosphatase-based system, which required quenching the endogenous enzymatic
activity of the eosinophils. One compound which has been formulated for this purpose
is levamisole, which was recommended and supplied by the same company as the
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Figure 3

Epifluorescent Micrograph of AUG Rat Peritoneal Leukocytes
Showing Non-specific Fluorescein Deposition

Figure 4

Epifluorescent Micrograph Showing Cellular Autofluorescence.
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labeling kit itself This kit employed a substrate system which yielded an intense red
precipitate upon catalysis. Cells stained using this system still had an unacceptably
high level of background, prima1ily in the cytoplasm

Once again, the negative

controls, which should have shown no labeling, were stained with the red precipitate.
To confirm that the problem was in the endogenous alkaline phosphatase activity of
the eosinophils, and not simply in a cross-reactive secondary antibody, the substrate
portion of the kit was used alone on one of our cell preparations with no antibodies
present. The cells showed the same distinct cytoplasmic labeling as before, even after
treatment with levamisole. We decided to forgo further attempts to overcome the
problems associated with the ABC-AP kit, which for reasons to be described, was a
fortuitous decision in that the system had another characteristic which would have
made it inappropriate for use in this cell population.
Glucose oxidase activity is not generally present in mammalian cells, and so
this enzyme has become widely used in biological sciences as a labeling reagent. The
kit which we used coupled the oxidation of glucose with the reduction of tetrazolium
salts to colored, insoluble precipitates.

When we applied the kit to our cell

preparation, however, no color developed under a variety of staining and washing
conditions, even on the small lymphocytes which we used as the internal positive
control. We then repeated the experiment using a primary mAb against a different
adhesion molecule, LFA-1, which is known to be present on eosinophils (Walsh,
Wardlaw & Kay, 1993), as well as other cells in the population under study (Pigott &
Power, 1993). Still, no color developed. Suspecting problems with the reagents, we
tested each of the individual components of the kit (kindly resupplied by the
manufacturer), which all appeared to function properly.

In a final side-by-side

comparison, several slides bearing the cell preparation were run along with others that
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had no cells, only the secondary Ab air-dried to the slide.

The result of this

experiment was that the non-cell slide stained strongly, while the cell-containing slides
remained devoid of color.

We concluded that some unknown factor in the cell

preparation was interfering with the production of the colored precipitate, and rather
than attempt an in-depth analysis of the problem, we would take another approach.
In returning to an examination of the feasibility of using fluorescein, we availed
ourselves of the work of Johnson & Bienenstock (1974), who found that a stain which
had been described in 1944 (Lendrum, 1944), had the additional beneficial property of
binding to the cytoplasmic granules of eosinophils with a higher affinity than
fluorescein. In our laboratory, using Lendrum's chromotrope at any point before the
application of fluorescein-conjugated antibodies removed cytoplasmic accumulation of
the fluorescein compounds, and resulted in the development of a deep orange-red
color under UV-excitation, which contrasts well with the green of the fluorescein.
Our assay was still one step from being complete.
The kits we had previously tested were designated "ABC" kits by the
manufacturer, because they employ an avidin-biotin complex to enhance the intensity
of labeling. In this system, the secondary antibody is conjugated to biotin rather than
to an enzyme or fluorochrome. The marker portion of the system is conjugated to
avidin, a glycoprotein of approximately 68 kD, which binds to biotin (Hsu, Raine &
Fanger, 1981) with an extremely high affinity (the manufacturer's catalog states that
the affinity is over one million times the affinity of most antibodies for their antigen).
Multiple biotinylation of the secondary antibody increases the marker deposited at the
site of the antigen under study, thus significantly amplifying the label. In our case,
however, we found labeling on the negative control slides, which had not been treated
with primary antisera. This suggested that there was some biotin-like epitope present
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on cells from this preparation, and that the avidin-biotin system would have to be
abandoned.
Even without the benefits of an avidin-biotin system, we did have a protocol
that circumvented the problems associated with fluorescein labeling, and felt that the
assay would be functional if the molecule under study were expressed at sufficient
levels. Many variations were evaluated to find optimum blocking, washing, labeling
and mounting conditions. Finally with the assay in hand, we were prepared to address
biological questions concerning expression of adhesion molecules on the surface of
eosinophils from the AUG rat peritoneal cavity.

MATERIALS AND :METHODS
Experimental Design
Cells were obtained from animals 14 days post-infection with the helminth
parasite Nippostrongylus brasiliensis, and from uninfected control animals. The cells
were then cultured with immune serum from previously infected animals and Nb
antigen or with immune serum alone. Cells were treated for O minutes or 20 minutes.
TA-2, an mAb against rat a4J31 integrin, was used as a marker to test for the
expression of the adhesion molecule in this mixed cell population.
Reagents
Except where noted, reagents were obtained from Sigma Chemical Co. (St.
Louis, MO). Ca++fMg++-free Hanks' Balanced Salt Solution (HBSS) was buffered
with 20mM N-[2-hydroxyethyl]piperazine-N'-(2-ethanesulfonic acid] (HEPES) at pH
7.3. Phosphate Buffered Saline (PBS) was 10 mM, pH 7.4. N brasiliensis culture
was the kind gift of Sandra Johnson of Pharmacia and Upjohn, and the working worm
preparation for in vitro exposure contained Nb larvae (1-:3) which had been maintained
in 60 ° C, reverse osmosis (RO) purified water until dead (about 14 days). Acetone
was placed in -20 ° C freezer before the experiment, to ensure the proper temperature
for fixation.

Lendrum's Chromotrope (LC) was prepared as previously described

(Johnson & Bienenstock, 1974): 0.1 g Chromotrope 2R was dissolved in 1.0 g melted
phenol crystals, and brought to 100 ml with the addition of glass-distilled water. LC
was stored in a light-tight glass container. Blocking solution was 0.1% EIA grade
21
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gelatin (Biorad, Richmond, CA) in PBS. The first batch of antisera (the mouse mAb
TA-2) was the kind gift of Anthony Manning, of Pharmacia and Upjohn; additional
antisera was purchased from Endogen (Cambridge, MA). The antisera was used at a
dilution of 1:50 in PBS. The secondary antibody was fluorescein-conjugated anti
mouse IgG (Vector Laboratories, Burlingame, CA) and was used at a dilution of
1: 100 in PBS.

Labeled slides were permanently mounted in Vectasheild® (Vector

Laboratories, Burlingame, CA). Differential staining was with DiflQuick® (Baxter
Healthcare Corporation, McGaw Park, IL), and total cell counts were performed using
a Neubauer Hemacytometer (American Opticai Buffalo, NY).

Animals
Six male August (AUG) rats (Harlan/Olac, UK) aged over 12 months were
used in this experiment, and were housed in accordance with Western Michigan
University Institutional Animal Care and Use Committee (IACUC) guidelines.
Animals were maintained with Rodent Chow® No. 5001 (Purina Mills, St. Louis, MO)
and RO purified water ad libitum.
The first group of 4 AUG rats were given a dose of approximately 3000
infective (L3) Nb larvae in 0.3 ml RO purified water by subcutaneous injection into the
proximal ventral surface of the right leg.

The remaining two rats were given no

injection and served as the control group.

Cell Isolation
On day 14 post-infection, animals were killed by COi inhalation and peritoneal
cells were isolated as previously described (Eversole, 1996). Briefly, after creating a

23
small ventral incision in the abdomen, 30 ml cold (wet ice) Ca++fMg++-free HBSS, was
placed in the animal's peritoneal cavity. After gently massaging the animal for one
minute, the HBSS and suspended cells were removed with a disposable syringe. Cells
were then centrifuged at 200 x g for 10 minutes at 4° C and the supernatant discarded.
The resulting pellet was resuspended in 5 ml HBSS and returned to wet ice. Blood
was also removed by cardiac puncture, allowed to coagulate on wet ice for 15
minutes. After coagulation was complete, this blood was centrifuged and the resulting
serum was kept on wet ice until needed.

Cell Treatment
Aliquots of 1.0 x 106 cells from the peritoneal lavages were added to 15 ml
centrifuge tubes containing 0.9 ml HBSS and 0.1 ml fresh immune serum, as well as to
tubes containing 0.9 ml HBSS, 0.1 ml fresh serum and 0.1 ml of the working Nb
preparation. Since each tube received 1.0 x 106 cells, the volume of cell suspension
added varied from animal to animal, but was always between 111-145 µl. Samples of
the cell suspension were removed either immediately (0 min) or after 20 min
incubation at 37 ° C, and placed on wet ice.

VLA-4Assay
®
Slides were made from these samples using a Cytospin3 centrifuge (Shandon

Inc., Pittsburgh, PA) . After centrifugation, a circle was drawn around each spot of
®

cells with a hydrophobic PAP pen (Kiyota International, Elk Grove Village, IL) to
prevent loss of reagent during the assay, and the barrier was allowed to air dry. Cells
were fixed in acetone for 10 minutes at -20 ° C, and washed 2 x 5 minutes in PBS.
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After the post-fixation washing, cells were exposed to gelatin blocking solution
in excess. Blocking was allowed to proceed overnight (10-12 hours) at 4 ° C. Slides
were washed 2 x 5 minutes in PBS.

Chromotrope was then added to all slides,

covering the cell area, and allowed to stand at room temperature for 30 minutes.
Slides were again washed 2 x 5 minutes in PBS. At this point, slides were divided into
a positive group (those receiving 100 µ1 of the mAb TA-2) and a negative control
group (which received additional blocking solution). Both groups were left to stand at
room temperature for 4 hours. Slides were again washed 2 x 5 minutes in PBS. The
secondary marker (a fluorescein-conjugated anti-mouse IgG) was added to all slides,
and allowed to stand for 30 minutes in the dark at room temperature. Slides were
®

again washed 2 x 5 minutes in PBS, Vectashield was added, and the slides were
coverslipped and sealed.
Epifluorescent microscopy was performed using a Microphot-FXA (Nikon,
Tokyo, Japan), and Micrographs were taken using Kodak (Rochester, NY) Elite II
400 ISO color slide film.

Computer-assisted Image Analysis
In order to more objectively determine if those cells which were deemed to be
labeled were different than those which were not and thus support the subjective
assessment of labeling, measurement of the cell brightness was carried out using a
Javelin JE462RGB black and white video camera (Javelin Electronics Corp., Tokyo,
Japan) mounted to a Nikon SMZ-U microscope, feeding images into a computer
running the Image-1 (Universal Imaging Corp., West Chester, PA) image-analysis
software system.

To avoid the inevitable photobleaching that would occur with

prolonged exposure of the cells themselves, the micrographs, which were on slide film,
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were analyzed under low magnification with backlighting.

Measurements of cell

brightness consisted of 5 separate average area brightness measurements of each cell,
taken exclusively from the nuclear region, except in the case of the mast cells, which
did not always present a clearly distinguishable nucleus under UV-excitation. The
nuclear area was chosen because it was the darkest area of the cell, with the minimum
autofluorescence
Subjective examination had suggested that eosinophils in particular exhibited
two very different labeling profiles, and that the proportions of eosinophils in these
groups varied with treatment (see Results). Since it was felt that this observation was
biologically relevant, we examined images representing 40 labeled eosinophils divided
equally between the higher and lower brightness levels.

Figure 5 represents the

distribution of cells with respect to brightness. It is important to recognize that these
40 cells do not represent a single treatment or infection state, but are selected to
represent the range of brightness observed subjectively. Clearly, the cells segregate
into two distinct groups on the basis of brightness, and while measurement of
additional cells would undoubtedly have smoothed the curves shown and perhaps even
partially filled the gap between the two groups, this is undoubtedly a case of two
distinct profiles.

These cells were the basis for our measurements of eosinophil

brightness, and the distinction made later between high and low-level labeling.
Additionally, eosinophils which were subjectively considered non-labeling were
measured for comparison.
The same measurement procedure was carried out for mononuclear cells and
mast cells, and 20 cells were counted for each of these cell types in both labeled and
non-labeled states, except in the case of mast cells whose low numbers in the
micrographs only allowed consideration of 13 cells, and which showed no labeling (see
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Distribution ofEosinophils With Respect to Brightness.
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Results).

Because all mast cells appeared non-labeled (see Results), additional

measurements were taken from cell-free regions of these micrograph for brightness
companson.
There are several relevant points to consider regarding the image analysis
portion of this study. It is important note that the. brightness was measured as a
unitless value, and not calibrated with a standard. Repeating these measurements with
another microscope or even the same microscope on different settings would likely
yield different values for brightness. Background (non-cell) brightness varied rather
consistently between all groups from less than 1 to approximately 20, compared to a
total study range of 1 to 180.

Several factors could influence these brightness

measurements, paiticularly length of exposure of the micrograph and small variations
of the intensity of the backlighting over different areas.
Also, because each cell population has different inherent brightness under UV
excitation, comparisons should not be drawn between the different cell types; for
example the highly labeled eosinophils were not necessarily twice as bright as the
labeling mononuclear cells, even though the data might appear to indicate that this was
the case.

RESULTS
Total numbers of cells in the peritoneal lavages of the infected group were
elevated approximately 59% above the levels in the uninfected group (see Table 1 and
Figure 6).

Total cell numbers and proportions of the individual cell types were

consistent with previous research (Eversole, 1996).
Morphological indications of the functional state of the cells were given by
®

examination ofDiffQuick -stained cells with light microscopy (an example is shown in
Figure 7). After 20 minutes of antigen-treatment, morphological changes were plainly
visible in eosinophils and mast cells, which were consistent with degranulation,
indicating a highly activated state. It was also possible to visualize granules from the
eosinophils and mast cells within mononuclear cells, indicating phagocytosis. In all
cases, eosinophils showed a marked morphological heterogeneity within each animal.
As with any antibody labeling procedure, there was some non-specific
deposition of the fluorescent marker.

Particularly in eosinophils, this non-specific

staining occurred within cytoplasmic vacuoles. As these vacuoles increased during
activation, the non-specific deposition of marker increased as well. True labeling was
taken as a fluorescence over the entire surface of the cell, particularly covering the
dark area of the nucleus. This labei when visualized by focusing through the depth of
the cell, had a three-dimensional character which was not exhibited by the non-specific
deposition.
Eosinophils from the non-infected animals did not express a4 (3 1 when initially
removed from the animal, nor did large numbers of cells express this molecule after 20
minutes of incubation with antigen at 37° C (Figure 8, Table 2). Figure 9 shows a
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Table 1
Total Cell Numbers and Differential Counts
Mean

Uninfected

(n=2)

Standard Dev.

Range

Mean

Infected

Standard Dev.

(n=4)

Range

Monocytes

60

4

56-64

60.5

4.33

53-63

Eosinophils

26.5

2.5

24-29

30

2.74

26-33

Mast Cells

8

1

7-9

5.75

2.78

3-8

Small Lymphocytes

5.5

.5

5-6

3.75

1.48

2-6

Total Cells (in millions)

25.75

1.75

41

5.04

34.63-45.13

24-27.5
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Figure 7.

Differentially Stained Peritoneal Lavage From Uninfected AUG Rat.

negative control, which had no primary antisera, and for comparison, Figures 10 & 11
show a slide which was nm through the entire assay but is considered to be non
labeling. Although not causing dramatic expression of a4 p I integrin, addition of Nb
antigen to the cell preparation did have an effect on overall eosinophil morphology and
apparent activation profile.
Eosinophils which had come from infected animals, however, showed
significant amounts of a4 p l upon removal from the animal, and that amount increased
after 20 minutes of incubation at 37 ° C (Figures 8, l2-l 7). Incubation with antigen
increased the percentage of cells labeling to a greater extent than incubation without
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Table 2
Percentage of Cells Showing Label
Mean

Uninfected Baseline
Standard Dev.

(n=2)
Range

Mean

Standard Dev.

Monocytes

1.5

0.5

1-2

21.25

7.12

Eosinophils

0

-

-

40.5

8.14

Mast Cells

0

-

-

0

Uninfected 20 min incubation (n=2)

(n=4)

Infected Baseline

Infected 20 min incubation

Standard Dev.

Range

12-30

31-52

(n=3)

17

Standard Dev.

3.0

Range

14-20

49

14.35

29-62

Eosinophils

0.5

0.5

0-1

53.67

17.75

34-77

Mast Cells

0

-

-

0

Monocytes

Mean

Mean

Uninfected 20 min with antigen
Standard Dev.

Range

Mean

(n=2)

Mean

Range

Infected 20 min with antigen (n=4)
Standard Dev.

Range

60.25

9.42

49-71

3-5

79.75

1.92

77-82

-

0

Monocytes

22

1.0

21-23

Eosinophils

4

1.0

Mast Cells

0

-

w
w
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Figure 9.

Epilluorescent Micrograph of Negative Control (no p1imary antisera).

antigen (Figure 8).
Image analysis confirmed that the cells which were considered labeled had a
higher brightness over the nucleus than those which had been designated non-labeled
(see Figure 18 and Table 2). It should be noted that two distinct groups of labeled
eosinophils were observed during data collection. The fu-st group had a lower level of
fluorescent intensity with a mean measmement of approximately 55, than the second,
more intense group, which had a mean of approximately 137 (see Table 3 and Figure
5). The few labeling eosinophils from non-infected animals were all of the low-label
variety. [n cells from the infected animals, less than 10% of the labeling eosinophils
were initially of the high-label va1iety, whereas after incubation with antigen, greater
than 50% of the labeling eosinophils were in the high-label condition (data not shown).
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Figure 10. Epilluorescent Micrograph of Non-labeling Cells.
This micrograph shows cells from an uninfected animal which have been incubated
with Nb antigen for 20 minutes at 37 ° C. While there is non-specific deposition of
marker, it is clearly distinguishable from the labeling which is shown in subsequent
micrographs.

Figure 11.

Phase-contrast Micrograph of Same Field-of-view Shown in Figure 10.
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Figure 12. Epilluorescent Micrograph of High-label Eosinphil.
This micrograph shows an eosinophil from an infected animal which had been exposed
to antigen for 20 minutes at 3 7 ° C. Note how the label is spread evenly over the
surface of the cell, including the nucleus.

Figure l3.

Phase Contrast Micrograph of Same Field-of-view Shown in Figme 12.
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Figure 14. Epilluorescent Micrograph of Low-label Eosinophils.
This micrograph is included to show the appearance of low-label eosinophils. This
micrograph shows an eosinophil from an infected animal which had been exposed to
Nb antigen for 20 minutes at 37 ° C.

Figure 15.

Phase-contrast Micrograph of Same Field-of-view Shown in Figure 14.
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Low Magnification Epifluorescent Micrograph of Labeled Eosinophils
Before Antigen Challenge.
This micrograph shows cells from an infected animal with no additional treatment.
There are labeled cells in this micrograph, however the low magnification makes
visualization of their low label difficult.
Figme 16.

Low Magnification Epifluorescent Micrograph of Labeled Eosinophils
After Antigen Challenge.
This micrograph shows cells from an infected animal after 20 minute expoure to Nb
antigen at 37° C. Despite the low magnification, the highly labeled cells are plainly
visable.
Figure 17.
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Table 3
Brightness Levels as Determined by Image Analysis

Monocytes (neg)
Monocytes (pos)
Eosinophils (neg)
Eosinophils (low)
Eosinophils (high)
Mast Cells
Background

Mean

Standard Dev.

Range

14.9
59.8
13.9
55.0
176.7
9.0
6.8

9.41
42.17
7.56

2.4-39.8
19.8-164.2
3.6-28.8
35.4-90.0
102.8-180.4
2.0-20.0
1.4-12.8

13.62
22.29
5.08
4.79

.j:::.
0
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Because it was not always possible to distinguish between the various types of
mononuclear cells with certainty, they were considered as a group.

Small

lymp hocytes, which were grouped with the other types of mononuclear leukocytes,
served as the positive control in this experiment, as some subsets of this population are
known to express a4131 integrin (Pigott & Power, 1993). Additionally, previous trials
in our laboratory had shown some of these cells to label, even under conditions in
which no other cells in the preparation showed any detectable label.
While there were a limited number of mononuclear lymphocytes which showed
labeling in the non-incubated cells from uninfected animals, the label was distinct and
easily visualized, and was limited to cells which were smaller than those which were
obviously macrophages. With incubation, the numbers of labeling mononuclear cells
increased (Figure 19), but it was beyond the scope of this study to determine which
specific cell types were most affected.
Figure 20 shows what appear to be two different types of mononuclear
lymphocytes; the smaller cell, which shows a more intense label, was the type of cell
used as a positive control, while the lager, less intense cell appears to be a
macrophage.

Figure 20 shows cells from an uninfected animal which had been

incubated with no antigen. Mononuclear lymp hocytes from infected animals showed
significantly higher labeling initially, and the percentage of cells labeling increased
significantly with incubation, although incubation with antigen was not clearly more
effective in eliciting a4131 integrin expression on these cells than incubation alone
(Figures 19, 21-22).
Image analysis of mononuclear cells revealed that differences in brightness
were detectable between cells considered labeled and those considered non-labeled
(see Figure 23). Within the labeled cells, there were examples of cells which were
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Figme 20. Epifluorescent Micrograph of Labeled Mononuclear Lymphocyte.
Th.is micrograph is from an uninfected animal with 20 minutes of incubation at 37 ° C,
but no Nb antigen. Th.is micrograph shows several cells, including two unlabeled
eosinophils, a large mononuclear cell, perhaps a macrophage, and a distinctly-labeled
small lymphocyte. These small lymphocytes were the cells which served as a positive
control in this experiment.
over twice as bright as the average, but these cells were too few to consider
separately, so they were incorporated into the group of all labeling mononuclear cells.
Mast cells did not label in this assay. Figure 24 shows a group of cells under
phase-contrast microscopy, while Figure 25 shows the same group of cells under UV
excitation, with the mast cell becoming virtually invisible.

Figure 26 shows the

relationship between the b1ightness of mast-cells under UV-excitation and cell-free
regions of the same micrographs (see also Table 2). Interestingly, the image analysis
equipment was able to detect the minute differences in b1ightness between mast cell
and background even when these differences were not visible to the eye.
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Figure 21.
Epilluorescent Micrograph of Highly Labeled Mononuclear Cells.
This micrograph shows cells from an infected animal which had been incubated with
Nb antigen for 20 minutes at 37 ° C.

Figure 22.

Phase Contrast Micrograph from the Same Field-of-view as Figure 21.
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Figure 24.

Phase Contrast Micrograph of Peritoneal Leukocytes, Including a Mast
Cell.

Figure 25.

Epilluorescent Micrograph of the Same Field-of-view as Figure 24.
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DISCUSSION
In this study, we have shown that the mAb designated as TA-2 is useful for in
vitro immunohistochemical protocols using AUG rat eosinophils.

We have also

developed a novel protocol for labeling experiments using AUG rat peritoneal
leukocytes in vitro, with emphasis on eosinophils. This protocol can now be used,
with the addition mAb against other cell-surface molecules, to continue research on
this important cell population.

Previous studies of eosinophil adhesion molecule

expression, which focused solely on binding phenomena, do not address specific
expression of the a4(31 molecule itself As described earlier, cells appear capable of
regulating integrin expression at the cell surface and integrin/ligand binding
independently. Our method of direct visualization offers a straightforward means of
localizing adhesion molecule expression in situ, which will be important to further
understanding of the detailed mechanisms of eosinophils' cell-cell and cell-ECM
interactions.
Furthermore, this study confirms that rat eosinophils express a4(3 1 integrin,
and that this expression can be increased with appropriate stimuli. It is interesting that
in our model, few eosinophils from uninfected animals showed significant amounts of
a4(3 1, nor did large numbers of these cells express this molecule after in vitro exposure
to Nb antigen, while eosinophils from infected animals not only showed more of the
molecule directly from the anima� but also expressed more a4(3 1 after antigen
challenge in vitro. This points to some form of in vivo functional priming connected
with the infection which was required for a4(3 1 expression by the cells. Previous
studies in our lab (Phipps, unpublished observations) have used a number of treatments
48

49
including antigen, extracellular matrix molecules, and specific culture techniques, in
attempts to stimulate eosinophils in vitro to produce a4 f3 1 . None of the protocols we
have tried has resulted in a level of expression even remotely comparable to the levels
produced by the eosinophils from the infected animals. The exact mechanism of this in
vivo priming remains unknown. It is worth noting that eosinophils in our preparation

have shown that degranulation and a4 f3 1 integrin production can be controlled
independently, since cells from non-infected animals showed morphological indications
of de granulation, but did not express a4� l ·
If our contention that an unknown and possibly complex priming mechanism is
necessary for a4 f3 1 integrin expression, how then does one account for studies
describing in vitro binding of eosinophils?

In one well-known study, human

eosinophils were shown to bind to fibronectin-coated plates, with optimum binding
taking place at one hour. The fact that this binding was significantly inhibited by the
anti-a4�1 mAb HP2/l shows rather strongly that it was mediated by a4 f3 1 .

The

source of the eosinophils, however, helps to explain this rapid binding: human
eosinophils were obtained from the blood of donors with allergy or asthma-associated
eosinophilia which suggests, on the basis of our results, that the cells had already
undergone some form of functional alteration.

While this study of blood-derived

eosinophils is useful in illuminating how a4 f3 1 mediates a specific signal transduction
mechanism, it is of doubtful usefulness in understanding eosinophil expression of the a
4 f3 1 integrin. This process for eosinophil collection is found throughout the literature.
In other studies, peripheral blood eosinophils from non-eosinophilic individuals are
used, but separation methods such as density gradients preferentially select eosinophils
with specific morphological profiles which may be linked to some form of activation.
One advantage of our animal model is that it uses a heterogeneous cell population.
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Our study cultured cells with immune serum from rats which had been infected
with Nb 14-21 days. This serum presumably contained antibodies or other factors
which may have had some effect on the eosinophils. Eosinophils are known to possess
receptors for several classes oflg's (reviewed in Giembycz & Barnes, 1993). It would
be interesting to determine what if any change would occur in the results if various
factors were removed from the serum. Similarly, our Nb antigen consisted of whole
killed worms, which certainly contain numerous factors, both soluble and insoluble.
The eosinophils in our preparation could have been reacting to a few very specific
antigens, or in a more general way toward the combination ofmany antigens.
Although we demonstrated the presence of a4131 on mononuclear leukocytes
the assay in its present state is not optimized for the study of these cells. Future
investigations would be improved with the addition of some staining protocol or other
method for discrimination of the different subsets of this cell population.
Although other investigators (Yasuda, Hasunuma, Adachi Sekine, Sakanishi,
Hashimoto, Ra, Yagita & Okumura, 1995), found a4131 on phorbol ester-stimulated
mast cells from the peritoneal cavities of rats using the anti-rat a4 mAb MRalpha4-1,
in our model of immune cell stimulation, mast cells did not at any time express a4131
integrin, even at incubation times up to 1 hour (Phipps, unpublished data). The reason
for this remains unclear, but may be due to differences in species, stimulation or
epitope recognition.
Even with the obstacles encountered in using computer-assisted image analysis
to study this modei we were able to demonstrate very significant differences between
what we considered labeled and non-labeled cells, thus lending an objective component
to our assessment of cell labeling.

Subjective observation had indicated that there

were within the group of all labeling eosinophils some which showed dramatically
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higher label, but without the aid of the image analysis system, this difference would
have been difficult to describe in a meaningful way.
The results of this study lead to several interesting questions.

What

mechanisms are involved in the in vivo functional priming of the eosinophils in the
infected animals? Were there factors in the immune serum which contributed to
increased a4f31 integrin expression?

And, perhaps more importantly, are these

mechanisms and factors part of the normal paradigm of eosinophil-mediated immunity?
In conclusion, we have developed an effective assay for localization of
a4f31 integrin on eosinophils from the peritoneal cavity of the AUG rat, which allows
us to determine with confidence whether or not this molecule is being expressed on
these cells. Our model provides an important means through which the expression of
adhesion molecules, in particular a4f31 on eosinophils, and the interactions between the
extracellular matrix and this important class of adhesion molecules can be investigated.
Furthermore, using this new technique we have clearly shown a connection
between Nb infection and the expression of a4f31 integrin on tissue eosinophils and
lymphocytes in this animal model. Finally, we have demonstrated that an in vitro
exposure of peritoneal leukocytes to antigens from Nb resulted in an increased
expression of a4f31 integrin by cells from infected animals which dramatically exceeded
the expression by identically exposed cells from uninfected animals.

Appendix.A
Protocol Clearance From the Institutional Animal
Use and Care Committee
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IACUC Number
Dare of Receipr
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Dare of Approval

WESTERN MICHIGAN UNIVERSITY
INSTITUTIONAL ANIMAL CARE
AND USE COMMITTEE (IACUC)
Application to use Vertebrate Animals for Research or Teaching
The use of any vertebrate animals in research and/or teaching without prior approval of the Institurional
Animal Care and Use Committee (IACUC) is a violation of Western Michigan University policies and
procedures. This Committee is charged with the institutional responsibility for assuring the appropriare
care and treatment of vatebrate animals.
Mail the signed original and five (5) copies of the typed application and any supplements to Research and
Sponsored Programs, Room A-221 Ellsworth Hall, (616) 387-3670.
Any application that includes use of hazardous materials, chemicals, radioisotopoes or biohazards must be
accompanied with SUPPLEMENT A.
Any application that includes survival surgery must be accompanied with SUPPLEMENT B.

or/Instructor

d;

i

387-5640
Campus Phone

�I

Signature

BIOS

L. Beuving

Department

Title of Project/Cour.;e

Check One:
I.

BIOS
7!:];_nt

387-5628
Campus Phone

Nippostrongylus brasiliensis infection in the August rat.

Teaching__

Research__
x_ Other______________ _

ANIMAL USE CA.TEGORIES (check ONLY one category)
A.

X

Projects that involve little or no discomfort (including injections).

B.

Projects that may result in some discomfort or pain, but of short duration.
Anesthetics, analgesics or tranquilizers� used.

C.

Projects that may result in significant discomfort or pain. Anesthetics, analgesics. or
a-anquilizers will nor be used.
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. �te Received
' � "i I .c
IACUC Number 'lq oe o I
First Reoewal Request _,._____
Second Renewal Request ____

-

WESTERN MICHIGAN UNIVERSITY
YEARLY RENEWAL FORM APPLICATION TO USE
VERTEBRATE ANIMALS FOR RESEARCH OR TEACHING
GENERAL INFORMATION: Fill in all appropriate information
R. Eversole

Principal Investigator/Instructor

7-5640

Campus Phone

Department

7-5628

BIOS

L Beuving

Responsible Faculty Member
(if PI not faculty member)
Title of Project/Course

Campus Phone

D=partrnent

Nippostrongylus brasiliensis ir.fection in the August Rat

PRINCIPAL INVESTIGATOR/INS1RUCTOR DECLARATION
I assure that I have obtained IACUC approval prior to implementing this project and that there are no
changes in the protocol submitted in the original application to use vertebrate animals for research or
teaching. I understand that if at any time changes are made in the use of animals as described in the
original application. a letter or amended protocol must be filed for review. I assure that the activities do
not unnecessarily d plic te previous experiments.

I
C/-

date

Z'i- JC'
Date

INS1TIVI10NAL ANIMAL CARE AND USE COMWTfEE APPROVAL

- --·/�cc :r'--ca-5l
iAcuc
�

Date

Ch·

PLEASE MAIL COMPLETED APPUCATION TO:
Research and Sponsored ProgrJ.ms
Western Michigan University
30 I Walwood Hall
K:ilJ.mazoo. Ml 49008
(616) 387-8270
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IACUC Number

10/91
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WESTERN MICHIGAN UNIVERSITY
ANIMAL USE APPLICATION - SUPPLEMENT A
HAZARDOUS MATERIALS
It is the principal investigator's responsibility to insure that all individuals who may come in
contact with a project are aware of hazards involved in the project. Review and approval by
Environmental Health and Safety office must be obtained before submission to IACUC.
Electron Microscopist
R. Eversole
387-5640
Position
Campus Phone
Principal Investigator/Instructor
5330 McCracken
Rl_QS
NOTE:

Department
Title of Project

Address
Nippostrongylos orasiliens·is infection in the August rat.

Biohazards: (Please List)
[nfectious Agent(s): Nipoostri:mexJn9 orasiJieosl',
Route(s) of Administration: -5uJJ..,fi..,r,..n.._r a.._...
oe
....
u...
o...
s....
J.J-Y-----,,---------------
Dosage(s): JO!JO. LJ larvae/an:fmaJ · ooe dose
Route(s) or Excretion: -"""'"-'"-.,.'---'·--v_,
[ndicate species at risk and virulence of agent(s): Baes only· Iaw (roi1d di aubea) ·
State specie(s) that will be exposed to the hazardous material:��-----------
Method of disposal of contaminated animal tissue including carcass(es): Standard operating prn(
0

0
_�_ _"---------------------

Chemical Hazards: (Please List)
Agenc(s) or Chemicals(s): ________________________
Route(s) of Administration: ________________________
Dosage(s): _____________________________
Route(s) or Excretion: --------------------�-----Is(are) the Agent(s) or Chemical(s) known or suspected carcinogens? _ _________
Method of disposal of contaminated animal tissue including carcass(es): __________
Radioisotopes: (Please List)
Agent(s) qr Chemicals(s): _________________________
Route(s) of Administration: _________________________
Dosage(s): �---------------------------Route(s) or Excretion: ___________________________
Time Period(s) for which the isotope(s) present(s) a Hazan:t _____________
Method of disposal of contaminated animal tissue including carcass(es): __________
Describe measures that will be taken to minimize the risks from all hazards indicated in this section.
Specify the procedures that will be used to decontaminate equipment prior to routine washing.
All caging will be segregated from rnmmno animal facilities PntiJ st11dy campLgt:i:.oR
Upon.·complec ion all equipment wi11 be antaclaved ca r>reveot 1113s coA;amiRatiol't.
This studv will be conducted in isolation from other rodent species CJ090 �cCrackeo ).
Reviewed and Approved by:
Manager, Environmental Health and Safety

� /17, �!h

.;: · ... .., ·1r, ·r,-.

f!/d/4 <I

n.,•:,

Co-Director, Radiation Safety (If applicable)
n .., ,,,
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II.

ANIMAL USE FACILITIES

The animal(s) will be housed and maintained in accordance with the WMU Humane Care and Use of I
Animals Policies and Procedures.
Yes_X__

No ___

If no, give explanation.

Please indicate the building and room(s) where the a.nimal(s) will be housed and cared for as well as I
the location ofthe experiments and procedures if different from where housed.
1090 McCracken

III.

Ref:
IV.

ANIMAL USE SUMMARY

In language understandable to a layperson, summarize your primary aims and describe the proposed
use of animals as concisely as possible. Bear in mind that the IA CUC is primarily interested in the
responsible, necessary, humane use of animals. Include a description of procedu res designed to
assure that discomfort and pain to animals will be minimized. It should include method of�;
method of� with test compound; and methods of euthanasia or djsposjtion of the animal after
the experiment

Su week old August rats will be injected subcutaneously with 3000 L3 stage
larvae of the rat nematode Nippostrongylus brasiliensis in 5ml of saline. These
animals will be killed by carbon dioxide inhalation on day 14 and day 21 post
infection. Tfie cells of the peritoneal and vascular compartments will then be
removed, counted and samples prepared for immunocytochemistry. The primary aims
of tfii.s: resea'l!cfi. is- <:0 asce·rtain tfie accumulation and activation status of the
easinopfiil leucocyte-s· in tne said compartments in this model of parasite immunity
The. dead animals will 5e· disposed according to standard operating procedures. De.at
;,!_ill be assured by open thorax cardiac puncture prior to disposal 1

0lgilvie, B.M., and Jones, V.E. (1971). Nippostrongylus brasiliensis: A review
of immunity and the host/parasite relationship in the rat. Exp. Parasitol, 21,
138-177
JUSTIFICATION FOR ALL ANIMAL EXPERIMENrS
Please provide a narrative with reference sources which addresses e.1ch of the following:

A.

B.
Ye...s.1

What assurance can be provided to indicate that the procedure is not duplicative?
Seyeral s.earches done to date have provided no references in the National
Library of "Medicine of this model in the August rat.

Have non-live animal techniques (e.g. � biological systems, computer simulation.
audiovisual demonstration) been considered? Explain why they have not been utilized.
This model of parasite frmnunitY requires. in vivo stodv in rats
2
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C.

Why has this species been selected for this procedure?

This rat possesses an inherent peritoneal eosinophilia and thus provides
a unique opportunity to study eosinophil biology.
D.

How many animals will be used in this project? How often will its procedures be done and
over what duration?

Three groups of six animals for a total of 18 will be utilized for one infec

to be run qver the next few months.
E.

In light of concern to minimize the number of animals used in experimentation, how will you
determine the number of animals to be used?

An (N) of six for these types of in-vivo experiments has proven to be a
statistical minimum.
NOTE:
F.

This study has 3 groups.

Items F, G, H and I require the approval of the Consulting Veterinarian.

What is the anticipated pain or distress response of the animal; and what is the duration of
discomfort? (Injections not included.)

�ild diarrhea is the only indicated pathology documented for this level of
Nippostr-ongylus infection.

Ten days.

G.

How will the pain in the animal be monitored?

H.

What sedative, analgesic, or anesthetics will be used, if any?
frequency of administration.

I.

What is the justification if pain relieving drugs are not used?

Daily behavioral observation

Include dose, route and

Animals that dfsplay any adverse pain response will be killed, Deatb by carbao

dioxide. inhalac ion and ooen thorax cardiac puncture.

3
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WESTERN MICHIGAN UNIVERSITY
INVESTIGATOR IACUC CERTIFICATE
Title of Project:

Nfppos-trongy1us orasiliensis infection in the August rat.

I
The information included in this IACUC application is accurate to the best of my knowledge. All
personnel listed recognize their responsibility in complying with university policies governing the care and!
use of animals.
I declare that all experiments involving live animals will be performed under my supervision or that ofi
another qualified scientist. Technicians or students involved have been trained in proper procedures in
animal handling, administration of anesthetics, analgesics, and euthanasia to be used in this project
If this project is funded by an extramural source, I certify that this application accurately reflects all
procedures involving laboratory animal subjects described in the proposal to the funding agency noted.
above.
Any proposed revisions to or variations from the animal care and use data will be promptly forwarded to··
the IACUC for approval.
___ Disapproved

/ Approved

___ Approved with the provisions listed below

Provisions or Explanations:

Signature: Principal Investigator/Il:l�tructor

Date

IACUC Chairperson Final Approval

Date

Approved IACUC Number

Rev. 3/92
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